JP2007530580A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007530580A5 JP2007530580A5 JP2007505191A JP2007505191A JP2007530580A5 JP 2007530580 A5 JP2007530580 A5 JP 2007530580A5 JP 2007505191 A JP2007505191 A JP 2007505191A JP 2007505191 A JP2007505191 A JP 2007505191A JP 2007530580 A5 JP2007530580 A5 JP 2007530580A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- medicament
- inflammatory
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55692704P | 2004-03-26 | 2004-03-26 | |
| PCT/US2005/009899 WO2005097780A1 (en) | 2004-03-26 | 2005-03-24 | [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007530580A JP2007530580A (ja) | 2007-11-01 |
| JP2007530580A5 true JP2007530580A5 (https=) | 2008-05-08 |
Family
ID=34964263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007505191A Abandoned JP2007530580A (ja) | 2004-03-26 | 2005-03-24 | 肥満細胞トリプターゼインヒビターとしての［４−（５−アミノメチル−２−フルオロ−フェニル）−ピペリジン−１−イル］−（４−ブロモ−３−メチル−５−プロポキシ−チオフェン−２−イル）−メタノンヒドロクロリド |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20070142435A1 (https=) |
| EP (1) | EP1737848A1 (https=) |
| JP (1) | JP2007530580A (https=) |
| KR (1) | KR20060130682A (https=) |
| CN (1) | CN1956978A (https=) |
| AR (1) | AR048336A1 (https=) |
| AU (1) | AU2005230934A1 (https=) |
| BR (1) | BRPI0509245A (https=) |
| CA (1) | CA2560649A1 (https=) |
| CR (1) | CR8603A (https=) |
| DO (1) | DOP2005000039A (https=) |
| EC (1) | ECSP066878A (https=) |
| IL (1) | IL178031A0 (https=) |
| MA (1) | MA28547B1 (https=) |
| MX (1) | MXPA06010610A (https=) |
| NO (1) | NO20064811L (https=) |
| PA (1) | PA8627601A1 (https=) |
| PE (1) | PE20060084A1 (https=) |
| RU (1) | RU2330034C1 (https=) |
| TN (1) | TNSN06278A1 (https=) |
| TW (1) | TW200602035A (https=) |
| UA (1) | UA83738C2 (https=) |
| UY (1) | UY28821A1 (https=) |
| WO (1) | WO2005097780A1 (https=) |
| ZA (1) | ZA200607752B (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20071148A1 (es) * | 2006-03-29 | 2007-12-10 | Sanofi Aventis | Mejoras en la preparacion de intermedios que conducen a hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona |
| AR065616A1 (es) * | 2007-03-07 | 2009-06-17 | Sanofi Aventis | Sintesis regioselectiva de ullmann de acido 4- bromo-3- metil-5- propoxi- tiofeno-2- carboxilico |
| WO2008115912A1 (en) * | 2007-03-21 | 2008-09-25 | Sanofi-Aventis | Regio-specific synthesis of 4-bromo-3-methyl-5-propoxy-thiophene-2-carboxylic acid |
| AR065859A1 (es) * | 2007-03-29 | 2009-07-08 | Sanofi Aventis | Ester de 2,5-dioxo-pirrolidin-1-ilo de acido 4-bromo-3-metil-5-propoxitiofen-2- carboxilico ,su sintesis regioespecifica y un intermedio del mismo |
| AR065858A1 (es) * | 2007-03-29 | 2009-07-08 | Sanofi Aventis | Metodo para preparar el inhibidor de triptasa [ 4-(5-aminoetil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona. |
| JP2011504499A (ja) * | 2007-11-21 | 2011-02-10 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | トリプターゼ阻害剤として使用するためのスピロピペリジン |
| DK2242477T3 (da) * | 2008-01-24 | 2013-01-21 | Soligenix Inc | Topisk aktive steroider til anvendelse ved interstitiel lungefibrose |
| RS54413B1 (sr) | 2008-08-22 | 2016-04-28 | Sanofi | [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-[7-fluoro-1-(2-metoksi-etil)-4trifluorometoksi-1h-indol-3-il]metanon kao inhibitor triptaze iz mastocita |
| AR074776A1 (es) | 2008-12-18 | 2011-02-09 | Sanofi Aventis | Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente |
| FR2955324A1 (fr) * | 2010-01-15 | 2011-07-22 | Sanofi Aventis | [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones disubstituees |
| SG179201A1 (en) * | 2009-09-24 | 2012-05-30 | Sanofi Aventis Us Llc | Synthesis of (4-fluoro-3-piperidin-4-yl-benzyl)-carbamic acid tert-butyl ester and intermediates thereof |
| RU2012131327A (ru) * | 2009-12-23 | 2014-02-10 | Санофи | Лечение воспалительного заболевания кишечника |
| AU2010333779A1 (en) * | 2009-12-23 | 2012-07-12 | Sanofi | Indolyl-piperidinyl benzylamines as beta-tryptase inhibitors |
| WO2011087652A1 (en) * | 2009-12-23 | 2011-07-21 | Sanofi | Tropinone benzylamines as beta-tryptase inhibitors |
| AU2011220909A1 (en) * | 2010-02-24 | 2012-09-13 | Sanofi | Treatment of dermatological allergic conditions |
| AP2014007606A0 (en) | 2011-10-07 | 2014-05-31 | Takeda Pharmaceutical | 1-Arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases |
| JP6995127B2 (ja) * | 2017-02-10 | 2022-02-04 | ジェネンテック， インコーポレイテッド | 抗トリプターゼ抗体、その組成物、及びその使用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| OA12274A (en) * | 2000-05-22 | 2006-05-09 | Aventis Pharma Inc | Arylmethylamine derivatives for use as tryptase inhibitors. |
| GB0012362D0 (en) * | 2000-05-22 | 2000-07-12 | Aventis Pharma Ltd | Chemical compounds |
-
2005
- 2005-03-21 DO DO2005000039A patent/DOP2005000039A/es unknown
- 2005-03-22 PE PE2005000325A patent/PE20060084A1/es not_active Application Discontinuation
- 2005-03-23 UY UY28821A patent/UY28821A1/es unknown
- 2005-03-23 AR ARP050101170A patent/AR048336A1/es not_active Application Discontinuation
- 2005-03-24 WO PCT/US2005/009899 patent/WO2005097780A1/en not_active Ceased
- 2005-03-24 EP EP05731154A patent/EP1737848A1/en not_active Withdrawn
- 2005-03-24 RU RU2006137717/04A patent/RU2330034C1/ru not_active IP Right Cessation
- 2005-03-24 KR KR1020067019886A patent/KR20060130682A/ko not_active Withdrawn
- 2005-03-24 MX MXPA06010610A patent/MXPA06010610A/es not_active Application Discontinuation
- 2005-03-24 CA CA002560649A patent/CA2560649A1/en not_active Abandoned
- 2005-03-24 BR BRPI0509245-0A patent/BRPI0509245A/pt not_active IP Right Cessation
- 2005-03-24 UA UAA200611261A patent/UA83738C2/ru unknown
- 2005-03-24 CN CNA2005800164250A patent/CN1956978A/zh active Pending
- 2005-03-24 JP JP2007505191A patent/JP2007530580A/ja not_active Abandoned
- 2005-03-24 AU AU2005230934A patent/AU2005230934A1/en not_active Abandoned
- 2005-03-25 TW TW094109209A patent/TW200602035A/zh unknown
- 2005-03-28 PA PA20058627601A patent/PA8627601A1/es unknown
-
2006
- 2006-09-07 CR CR8603A patent/CR8603A/es not_active Application Discontinuation
- 2006-09-12 TN TNP2006000278A patent/TNSN06278A1/en unknown
- 2006-09-12 IL IL178031A patent/IL178031A0/en unknown
- 2006-09-14 US US11/520,998 patent/US20070142435A1/en active Granted
- 2006-09-15 ZA ZA200607752A patent/ZA200607752B/en unknown
- 2006-09-22 EC EC2006006878A patent/ECSP066878A/es unknown
- 2006-10-20 MA MA29405A patent/MA28547B1/fr unknown
- 2006-10-23 NO NO20064811A patent/NO20064811L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007530580A5 (https=) | ||
| JP5567252B2 (ja) | グリコピロレートおよびベータ２アドレナリン受容体アゴニストの組合せ剤 | |
| RU2006137717A (ru) | [4-(-аминометил-2-фторфенил)-пеперидин-1-ил]-(4-бром-3-метид-5-пропокситиофен-2-ил)-метанон гидрохлорид как ингибитор триптазы тучных клеток | |
| US20100166671A1 (en) | Organic compounds | |
| JP2010215637A (ja) | β２−アゴニストの溶液を含有する加圧式定量用量吸入器 | |
| CA2496699A1 (en) | Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids | |
| RU2008129600A (ru) | Комбинация и фармацевтический препарат для лечения воспалительных заболеваний | |
| JP2009535340A5 (https=) | ||
| CN1341017A (zh) | 用于治疗气喘的福莫特罗和糖酸莫米松的组合 | |
| AU2012216890A1 (en) | Combination of glycopyrrolate and a beta2 -agonist | |
| JP2017526716A5 (https=) | ||
| JP2019528316A5 (https=) | ||
| CN101657191B (zh) | 包括福莫特罗和二丙酸倍氯米松的组合物在制备用于预防和/或治疗哮喘恶化的药物中的用途 | |
| CA2575932A1 (en) | Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases | |
| JP2022520990A (ja) | 呼吸器疾患の治療の方法 | |
| KR20080068085A (ko) | 삼중-조합 요법을 이용한 천식 및 ｃｏｐｄ의 치료 | |
| ES2319887T3 (es) | Formulacion superfina de salmeterol. | |
| CN106470700A (zh) | 用于治疗copd的噻托溴铵、福莫特罗和布地奈德的组合 | |
| JP2009516662A (ja) | グリコピロニウム塩を含む有機化合物 | |
| KR20080069197A (ko) | 염증성 및 폐쇄성 기도 질환의 치료를 위한 제약 조성물 | |
| JP2016506947A (ja) | 吸入療法において使用するのに適する多成分結晶粒子を含む医薬組成物 | |
| UY30935A1 (es) | Combinacion:-antagonista del receptor de quimioquina 1 (ccr1) -agonista del receptor de glucocorticoides- opcionalmente agonista b(beta)2, -composicion farmacéutica conteniéndola -aplicaciones. | |
| JP2010538010A5 (https=) | ||
| JP2006501207A5 (https=) | ||
| JP2008533079A5 (https=) |